Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease (Q44477953)

3 December 2017

title

Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease (English)

1 reference

3 December 2017

0 references

1 reference

1 reference

1 reference

3 December 2017

1 reference

3 December 2017

Maikel P Peppelenbosch

object named as

Maikel P Peppelenbosch

0 references

author name string

Jan M H Van den Brande

1 reference

3 December 2017

Gijs R van den Brink

1 reference

3 December 2017

Christiaan A Bauer

1 reference

3 December 2017

Inge Hoedemaeker

1 reference

3 December 2017

Catherine van Montfrans

1 reference

3 December 2017

Daan W Hommes

1 reference

3 December 2017

Sander J H van Deventer

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

124

1 reference

3 December 2017

1 reference

3 December 2017

page(s)

1774-1785

1 reference

Tumor necrosis factor: biology and therapeutic inhibitors

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

The pathophysiology of tumor necrosis factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Tumour necrosis factor alpha in stool as a marker of intestinal inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Construction and initial characterization of a mouse-human chimeric anti-TNF antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Apoptosis: one of the mechanisms that maintains unresponsiveness of the intestinal mucosal immune system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Isolation and functional characterization of human intestinal mucosal lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Immunosuppressive properties of methotrexate: apoptosis and clonal deletion of activated peripheral T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

A sensitive assay for detecting low-affinity interactions at the cell surface reveals no additional ligands for the adhesion pair rat CD2 and CD48

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

A novel addition to the T cell repertory. Cell surface expression of tumor necrosis factor/cachectin by activated normal human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Tumor necrosis factor receptor expression in HIV-1-infected CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Chimeric anti-TNF-α monoclonal antibody cA2 binds recombinant transmembrane TNF-α and activates immune effector functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Protective effect of 55- but not 75-kD soluble tumor necrosis factor receptor-immunoglobulin G fusion proteins in an animal model of gram-negative sepsis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

A casein kinase I motif present in the cytoplasmic domain of members of the tumour necrosis factor ligand family is implicated in 'reverse signalling'

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Blockade of interleukin 6 trans signaling suppresses T-cell resistanceagainst apoptosis in chronic intestinal inflammation: Evidence in Crohn diseaseand experimental colitis in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

Cell death induction by receptors of the TNF family: towards a molecular understanding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2803%2900382-2

10.1016/S0016-5085(03)00382-2

7 January 2021

Identifiers

DOI

1 reference

3 December 2017

1 reference